Prognostic value of plasma biomarkers GFAP and pTau181 for all-cause and Alzheimer’s dementia Published 2024-05-07 Download video MP4 360p Download video MP4 720p Recommendations 05:19 Examining plasma vs. CSF p-tau217 in preclinical and prodromal Alzheimer’s disease 04:22 Prognostic accuracy of plasma NfL to predict Alzheimer’s disease dementia 04:40 Understanding Parkinson’s Disease 18:40 Matthew Perry's death from Ketamine explained (is it safe for you?) 12:04 Why is Everyone Going Blind? The UGLY TRUTH behind the myopia epidemic 05:15 Diagnostic performance of plasma p-tau217 in a memory clinic cohort 1:14:20 Dementia could start in your blood vessels - eat these foods to keep your mind sharp | Dr William Li 01:53 Assessing the value of immunotherapy in mesothelioma 03:09 How are blood-based biomarkers currently used in Alzheimer’s disease? 04:28 Very high risk non-muscle-invasive bladder cancer (NMIBC) in the current landscape of NMIBC 12:34 Stop trying to lose weight. Do this instead. (Secrets from a Biochemist) | Episode 16 of 18 14:46 Excess Deaths at Night - Obstructive Sleep Apnea Explained Clearly 03:31 ALZ-801 Phase II data & launch of Phase III study in early Alzheimer’s disease 02:39 Distinguishing between late-onset primary psychiatric disorders and dementia 01:34 Strategies to improve the response to immunotherapy in TNBC 01:53 LEADS: shedding light on early-onset Alzheimer's disease 01:44 Challenges in fluid biomarker development in Alzheimer's disease research 01:44 Radiotherapy for breast cancer increases risk of cardiovascular disease 02:11 Differential diagnosis from limb-girdle muscular dystrophies 01:12 ALZ-801 in combination with anti-amyloid antibodies for the treatment of Alzheimer’s disease Similar videos 1:00:12 Fluid Biomarkers in Dementia: An Update - Clinical Core Webinar - April 23, 2021 1:01:17 Douglas Galasko, MD - CSF and Blood Biomarkers for Alzheimer's 08:41 pTau in Plasma- the next NfL? 1:25:29 Neurology Webinar 3 - Alzheimer's Disease 51:51 Douglas Galasko, MD., Paula Desplats, Ph.D., - Biomarker Interest Group: Fluid Biomarkers for AD... 1:59:47 Molecular Biomarkers of Neurodegeneration - Ace Global Research Summit 2021 49:37 Douglas Galasko, MD-New Treatments and Research for Alzheimer’s Disease and Related Disorders 54:54 LMP Grand Rounds MMielke 5Dec2018 45:16 Biomarker Use for Evaluating mTBI: A Game-changing New Technology 54:32 Advances in Alzheimer’s Disease: Integrating the New Diagnostic Tools and DMTs Into Practice 1:00:07 2022 CERSI Summit - Panel 2: Biomarkers and Surrogate Endpoints: Alzheimer’s as a Prototype 4:33:38 Cognitive Aging Summit IV (CAS IV) Day 2 1:53:15 Workshop Down Syndrome Research and Advocacy Parte 04 1:02:06 Understanding Subjective Cognitive Decline_20231208 More results